The serum level of ALT was significantly higher in the group of Ru-1-treated tumor-bearing mice in comparison with Ru-2 and oxaliplatin-treated and control mice (significant difference from: Ru-2 group (p = 0.015); control group (p = 0.018); Figure 9C). The gene discussed is GPT; the disease is neoplasm.